VYGR — Voyager Therapeutics Share News
0.000.00%
Last trade - 00:00- $107.22m
- -$9.12m
- $40.37m
Voyager Therapeutics slides as $100 mln stock offering priced
Brief: Voyager Therapeutics Announces Pricing Of An Underwritten Public Offering Of 7.78 Mln Shares At A Price Of $9.00 Per Share
Brief: Voyager Therapeutics Announces Proposed Public Offering
Voyager Therapeutics slides on stock offering
U.S. STOCKS ON THE MOVE-Coherus, Moderna
U.S. STOCKS ON THE MOVE-Rivian, Terran Orbital, Longboard Pharmaceuticals
Voyager Therapeutics rises on deal with Novartis to develop gene therapy candidates
U.S. STOCKS ON THE MOVE-Apple, NGM Biopharmaceuticals, Voyager Therapeutics
Voyager Therapeutics rises on deal with Novartis to develop gene therapy candidates
Novartis signs gene therapy deal with Voyager for $100 mln upfront (updated)
Brief: Voyager Therapeutics Enters Capsid License Agreement And Strategic Collaboration With Novartis To Advance Novel Gene Therapies
Novartis signs gene therapy deal with Voyager for $100 mln upfront
Brief: Voyager Therapeutics Inc Announces Selection Of Development Candidate For SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
Brief: Voyager Therapeutics Q3 EPS USD -0.59
Voyager Therapeutics Inc expected to post a loss of 58 cents a share - Earnings Preview
Brief: Voyager Therapeutics Announces Appointment Of Beth Shafer As Chief Business Officer
Voyager Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Voyager Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Sangamo Therapeutics And Voyager Therapeutics Enter License Agreement